Friday, November 15, 2024 4:11:58 PM
5 million shares traded based on what Carter and Nasrat said in today's CC. So all sales today were either
- someone listening to the CC deciding to buy
- day traders watching stock action
- people following this board
Once we get a transcript with the details put out there and possibly a followup article from Zacks or someone else we should see another surge up.
Keep in mind that our last CC on Aug 15 the stock opened at $0.20 and closed at $0.19. Even though Nasrat told us amazing news of the re-purchase of a billion dollar in products during that call and his intention to begin a launch of new products every 6 to 8 weeks starting in about a week from the call. In fact, the stock didn't start moving up until Aug 26, a week and a half later. Thats how long it took to get the attention of more investors.
Today we lifted off as soon as we heard a whiff of good news. We obviously have more eyes on the stock. I expect next week to be rocking once more investors see the Nov 23rd Vyvanse decision date in print. That is the day the FDA told Elite they will give them an answer (Yes, Nasrat noted that is a Sat, but he said that is the date the FDA gave him).
- someone listening to the CC deciding to buy
- day traders watching stock action
- people following this board
Once we get a transcript with the details put out there and possibly a followup article from Zacks or someone else we should see another surge up.
Keep in mind that our last CC on Aug 15 the stock opened at $0.20 and closed at $0.19. Even though Nasrat told us amazing news of the re-purchase of a billion dollar in products during that call and his intention to begin a launch of new products every 6 to 8 weeks starting in about a week from the call. In fact, the stock didn't start moving up until Aug 26, a week and a half later. Thats how long it took to get the attention of more investors.
Today we lifted off as soon as we heard a whiff of good news. We obviously have more eyes on the stock. I expect next week to be rocking once more investors see the Nov 23rd Vyvanse decision date in print. That is the day the FDA told Elite they will give them an answer (Yes, Nasrat noted that is a Sat, but he said that is the date the FDA gave him).
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
